Phase I Study for Safety and Efficacy of P276-00 in Subjects With Myeloma
Phase 1
Withdrawn
- Conditions
- Multiple Myeloma
- First Posted Date
- 2007-10-22
- Last Posted Date
- 2009-04-23
- Lead Sponsor
- Piramal Enterprises Limited
- Target Recruit Count
- 35
- Registration Number
- NCT00547404
Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms
Phase 1
Terminated
- Conditions
- Neoplasm
- First Posted Date
- 2006-12-05
- Last Posted Date
- 2009-01-01
- Lead Sponsor
- Piramal Enterprises Limited
- Target Recruit Count
- 28
- Registration Number
- NCT00408018
- Locations
- ๐ฎ๐ณ
Nizam's Institute of Medicai Sciences, Hyderabaad, Andhra Pradesh, India
๐ฎ๐ณGlobal Hospital, Hyderabad, Andhra Pradesh, India
๐ฎ๐ณTata Memorial Hospital, Mumbai, Maharashtra, India
Open Label Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms
Phase 1
Completed
- Conditions
- Neoplasm
- First Posted Date
- 2006-12-05
- Last Posted Date
- 2009-01-01
- Lead Sponsor
- Piramal Enterprises Limited
- Target Recruit Count
- 50
- Registration Number
- NCT00407498
- Locations
- ๐จ๐ฆ
Juravinsky Cancer Centre, Hamilton, Ontario, Canada
๐ฎ๐ณNizam's Institute of Medicai Sciences, Hyderabaad, Andhrapradesh, India
๐จ๐ฆKingston General Hospital, Kingston, Ontario, Canada
ยฉ Copyright 2025. All Rights Reserved by MedPath